|
Volumn 32, Issue 2, 2008, Pages 195-196
|
The anti-inflammatory activity of clarithromycin inhibits TNFα production and prolongs survival following lipopolysaccharide administration in mice
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BACTERIUM LIPOPOLYSACCHARIDE;
CLARITHROMYCIN;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIINFLAMMATORY ACTIVITY;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MECHANISM;
ENZYME LINKED IMMUNOSORBENT ASSAY;
LETTER;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SEPSIS;
SEPTIC SHOCK;
SURVIVAL TIME;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
CLARITHROMYCIN;
DISEASE MODELS, ANIMAL;
ESCHERICHIA COLI;
ESCHERICHIA COLI INFECTIONS;
HUMANS;
LIPOPOLYSACCHARIDES;
MICE;
MICE, INBRED BALB C;
SHOCK, SEPTIC;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 46049096309
PISSN: 09248579
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijantimicag.2008.03.016 Document Type: Letter |
Times cited : (12)
|
References (7)
|